March 29, 2017 4:47 AM ET

Pharmaceuticals

Company Overview of A. Menarini Industrie Farmaceutiche Riunite Srl

Key Executives for A. Menarini Industrie Farmaceutiche Riunite Srl

NameBoard RelationshipsTitleAge
Valeria Speroni Cardi No RelationshipsHead of Press Office--

A. Menarini Industrie Farmaceutiche Riunite Srl Board Members*

NameBoard RelationshipsPrimary CompanyAge
Lucia Aleotti 3 RelationshipsA. Menarini Industrie Farmaceutiche Riunite Srl--
Alberto Giovanni Aleotti 3 RelationshipsA. Menarini Industrie Farmaceutiche Riunite Srl--
Domenico Simone 3 RelationshipsA. Menarini Industrie Farmaceutiche Riunite Srl--
Juerg Witmer 3 RelationshipsA. Menarini Industrie Farmaceutiche Riunite Srl--
View All Board Members

A. Menarini Industrie Farmaceutiche Riunite Srl Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
339.7K
Bonus
404.7K
Total Short Term Compensation
472.6K
Total Value of Options
6.4M
Compensation as of Fiscal Year
A. Menarini Industrie Farmaceutiche Riunite Srl CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Laurus Labs Limited Announces Resignation of Frank J Wright as Director with Effect from March 31, 2017
March 27, 2017 2:54 PM ET
Impax Laboratories, Inc. Announces Executive Changes
March 27, 2017 1:00 PM ET
Tetra Bio-Pharma Inc. Appoints Edward Miller as Vice President, Investor Relations and Corporate Communications
March 27, 2017 12:42 PM ET
Amryt Pharma plc Appoints David Allmond as Chief Commercial Officer, Effective April 3, 2017
March 27, 2017 6:00 AM ET
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
March 24, 2017 11:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact A. Menarini Industrie Farmaceutiche Riunite Srl, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.